Different sexes and genders experience differentiated risks of acquiring infections, including
drug-resistant infections, and of becoming ill. Different genders also have different health …

Introduction Neisseria gonorrhea (N. gonorrhea) represents a significant causative agent of
sexually transmitted infections (STIs), posing considerable global health challenges. Despite …

In recent years, the potential of pathogenic bacteria to acquire resistance to a variety of
antimicrobial drugs has developed significantly due to the indiscriminate exposure of a …

Antibiotics are drugs that are used to treat or prevent bacterial infections. They work by either
killing or stopping bacteria from spreading. Nevertheless, it appeared in the last decade …

Antimicrobial drug resistance in Neisseria gonorrhoeae has been documented all over the
world. However, the situation in Sub-Saharan Africa has received little attention. It is critical …

Gonorrhea is an urgent antimicrobial resistance threat and its therapeutic options are
continuously getting restricted. Moreover, no vaccine has been approved against it so far …

Gonococcal infections present a notable public health issue, and the major approach for
treatment involves using β‐lactam antibiotics that specifically target penicillin‐binding …

Abstract In South Africa, basic healthcare centres treat sexually transmitted infections (STIs)
using a syndromic approach. In line with Preferred Reporting Items for Systematic Reviews …

The emergence of drug‐resistant strains of Neisseria gonorrhoeae poses a significant
global health challenge, necessitating the development of novel antimicrobial agents. This …

The gonorrhoea caused by the bacterium Neisseria gonorrhoeae remains a major global
public health problem with high morbidity. Gonorrhoea can affect both women and men …